T12	Treatment 89 109	high-dose cytarabine
T13	Subject 113 137	patients who develop PPE
T14	Effect 171 189	potential toxicity
T16	Dosage 89 98	high-dose
T17	Drug 99 109	cytarabine
T18	Speculation_cue 171 180	potential
T20	Treat-Disorder 134 137;287 312	PPE haematologic malignancies
